RARA CRAFT DATABASE for FDA Medical Devices
510(k)K173333

FDA DEVICE FACTS

GORE ENFORM Biomaterial

W. L. Gore & Associates, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 5, 2018PRODUCT CODEOXF

Indications for use

GORE® ENFORM Biomaterial is indicated for use in the reinforcement of soft tissue. This includes use in patients requiring soft tissue reinforcement in plastic and reconstructive surgery. Examples of applications where GORE® ENFORM Biomaterial may be used include hernia repair as suture line reinforcement, muscle flap reinforcement, and general tissue reconstructions.

Differences in Technological Characteristics

The GORE® ENFORM Biomaterial with film configuration, a fully absorbable device, contains a visceral protection film layer not present in the predicate GORE® BIO-A® Tissue Reinforcement. However, the GORE® SYNECOR lntraperitoneal predicate possesses a visceral protection film comprised of the same material as the GORE® ENFORM Biomaterial with film. (The permanent PTFE knit middle layer of the predicate GORE® SYNECOR is not present in the GORE® ENFORM Biomaterial devices and therefore, was not compared.) The predicate PHASIX™ ST, also a fully absorbable device, possesses a visceral protection layer comprised of a different material (hydrogel barrier).

Summary of Performance Testing

Biocompatibility: Biocompatibility evaluation appropriate for a tissue contacting implant with permanent duration of exposure was conducted according to “Use of International Standard /SO 10993-1, Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process". Guidance for Industry and Food and Drug Administration Staff. June 16, 2016”.

Bench study: The bench testing conducted included but was not limited to evaluation of surgical manipulation, suture needle penetration, stiffness, tensile strength. Results demonstrated that both configurations of the GORE® ENFORM Biomaterial met the performance criteria established for the indicated uses of the device.

Animal study: Animal studies were conducted to compare the performance of the ENFORM Biomaterial to the predicate control devices with respect to visceral protection, tissue ingrowth and tissue response.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 28, 2026